instruction:
Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
question:
"Quoting the study lead, the cost of ginger dietary supplements ranges from $6 to $30 for 50 to 100 capsules; however, as noted by the researchers, it is not apparent if dietary supplements would be as effective as the formulation developed specifically for the study. The study lead is quoted as saying the use of ginger resulted in a 40% improvement in patients’ nausea. In the placebo group, the study lead indicated that ""hardly any difference"" was noted. But we’re not given any context on important questions such as how much change in the nausea scale is actually clinical perceptible to patients. This is what’s really needed to understand any potential benefit. While there were no reported adverse effects associated with the use of ginger in this study, the story points out that ginger supplements can interfere with blood clotting, which can be particularly harmful to cancer patients undergoing treatment or surgery. The story suggests that people should talk with their doctors before using it. The story does not make it fully apparent that this research has not yet been published in a medical journal and only the abstract has been released. Unlike published articles, this study has not gone through a review process to check for errors in the methodology. While the story points out that 2/3 of the study participants were being treated for breast cancer, it would also be important to clearly state that the majority (90%) were women, which suggests that the results may not be applicable to the general population. Furthermore, it is not clear from the story or the abstract if patients received different types of chemotherapy or why the researchers included patients with various types of cancer. The story does not appear to exaggerate the prevalence of nausea as a side effect of chemotherapy treatment. In addition to interviewing the research lead, this story also includes quotes from a director at the American Cancer Society, as well as the president of the American Society of Clinical Oncology; however, the president of the oncology society did not comment directly on the research. The story mentions that the study was funded by the National Cancer Institute and researches did not have any ties with the capsule maker who supplied the ginger formulation for this study. The story briefly mentioned anti-emetics, which reduce vomiting, but more detail could have been supplied regarding the efficacy of other medications for chemotherapy-related nausea. Ginger capsules sold as dietary supplements and products containing ginger flavoring, such as ginger teas or ginger spice, are widely available; however, the story notes that they may not provide the same benefits as the formulation used in the study. According to the story, the company that developed the capsule used in this study is seeking approval from the FDA to market the ginger formulation as an anti-nausea drug. Up front, the story points out that ginger has long been used to quell nausea; however, it also mentions that this is the first large-scale study evaluating its efficacy in cancer patients receiving chemotherapy. Other studies, as this story indicates, have had conflicting results. This story does not appear to rely on a press release."
answer:
Study: Ginger capsules ease chemotherapy nausea


question:
Duck droppings from the central Dutch province tested positive for the highly contagious H5 strain of the disease, the deputy economic affairs minister wrote in a letter to parliament. “Based on this information I am considering follow-up measures,” deputy minister Sharon Dijksma wrote. Dutch authorities said earlier on Monday they will slaughter 50,000 birds at a poultry farm after bird flu was discovered nearby. Separate testing indicated that farm infections, which have led to the culling of around 300,000 birds at four locations, were not all from the same source, the letter said. The H5N8 strain of bird flu detected at the farms has never been founded in humans. It has led to the destruction of millions of farm birds in Asia, mainly South Korea, after an outbreak earlier this year. A government statement said tests had confirmed an outbreak of the H5N8 strain at one farm in the western municipality of Zoeterwoude, where 28,000 laying hens were ordered destroyed on Sunday. A cull at a nearby farm announced on Monday was a precautionary measure, it said. Animal health authorities are testing poultry at other farms in the area. Transport restrictions were imposed on the sector two weeks ago that have hit around 2,000 poultry businesses. The Netherlands is the world’s largest exporter of eggs and the largest exporter of poultry meat in the European Union. Some experts believe that wild birds migrating from Asia carried the disease to Europe, where it infected flocks in Germany, Britain and the Netherlands.
answer:
Dutch discover bird flu in wild ducks, cull continues.


question:
Tuesday’s unanimous jury decision in San Francisco federal court was not a finding of Bayer’s liability for the cancer of plaintiff Edwin Hardeman. Liability and damages will be decided by the same jury in a second trial phase beginning on Wednesday. Bayer, which denies allegations that glyphosate or Roundup cause cancer, said it was disappointed with the jury’s initial decision. Bayer acquired Monsanto, the longtime maker of Roundup, for $63 billion last year. Bayer shares were 12.5 percent lower at 1110 GMT, the biggest intraday loss in 16 years, wiping some 8 billion euros ($9.1 billion) off its valuation. “This looks like 2-0 plaintiffs, and clearly not helpful for the overall payout calculus and resolution of the litigation,” said Bernstein analyst Gunther Zechmann. Glyphosate is the world’s most widely used weed killer. Monsanto’s Roundup was the first glyphosate-based weed killer but is no longer patent-protected and many other versions are now available. Bayer does not provide sales figures for the product. “We are confident the evidence in phase two will show that Monsanto’s conduct has been appropriate and the company should not be liable for Mr. Hardeman’s cancer,” the company said. The case was only the second of some 11,200 Roundup lawsuits to go to trial in the United States. Another California man was awarded $289 million in August after a state court jury found Roundup caused his cancer. That award was later reduced to $78 million and is on appeal. Baader Helvea analyst Markus Mayer noted that Bayer management announced ambitious targets in December. “(It) is now under pressure to deliver and trying to avoid becoming a target for activist or strategic buyers.”  Activist investor Elliott already holds a stake of less than 3 percent in Bayer, Reuters disclosed last year. Brokerage Warburg lowered its recommendation to “Hold” from “Buy”, arguing that the with the renewed setback upcoming glyphosate court cases would remain a drag on the share price. Bayer had claimed that jury was overly influenced by plaintiffs’ lawyers allegations of corporate misconduct and did not focus on the science. U.S. District Judge Vince Chhabria called such evidence “a distraction” from the scientific question of whether glyphosate causes cancer. He split the Hardeman case into two phases: one to decide causation, the other to determine Bayer’s potential liability and damages. Under Chhabria’s order, the second phase would only take place if the jury found Roundup to be a substantial factor in causing Hardeman’s non-Hodgkin’s lymphoma. The jury found that it was on Tuesday. Union Investment fund manager Markus Manns cautioned that it was too early to read anything into individual rulings in courts of first instance. “What will be important for Bayer is the outcome of the appeals hearings,” he told Reuters, adding that Bayer should not yet engage in settlement talks. Chhabria has scheduled another bellwether trial for May and a third trial is likely to take place this year. All three cases will be split into causation and liability phases. The U.S. Environmental Protection Agency, the European Chemicals Agency and other regulators have found that glyphosate is not likely carcinogenic to humans. But the World Health Organization’s cancer arm in 2015 reached a different conclusion, classifying glyphosate as “probably carcinogenic to humans.”
answer:

Bayer shares slide after latest Roundup cancer ruling.